N29N

General Information


DRACP ID  DRACP00413

Peptide Name   N29N

Sequence  PDEDAINNALNKVCSTGRRQRSICKQLLKK

Sequence Length  30

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
SW480 Colon adenocarcinoma Carcinoma 100% cell viability at 5 µM Cell Viability assay 24 h 1
SW480 Colon adenocarcinoma Carcinoma 40% cell viability at 50 µM Cell Viability assay 24 h 1
U-937 Adult acute monocytic leukemi; Acute monoblastic/monocytic leukemia Leukemia 100% cell viability at 5 µM Cell Viability assay 24 h 1
U-937 Adult acute monocytic leukemi; Acute monoblastic/monocytic leukemia Leukemia <40% cell viability at 50 µM Cell Viability assay 24 h 1
SNU-1 Gastric adenocarcinoma Carcinoma <100% cell viability at 5 µM Cell Viability assay 24 h 1
SNU-1 Gastric adenocarcinoma Carcinoma <20% cell viability at 50 µM Cell Viability assay 24 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Lyse cancer cells

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00413

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C141H248N48O45S2

Absent amino acids  FHMWY

Common amino acids  K

Mass  391740

Pl  10.34

Basic residues  7

Acidic residues  3

Hydrophobic residues  8

Net charge  4

Boman Index  -9582

Hydrophobicity  -94

Aliphatic Index  81.33

Half Life 
  Mammalian: >20 hour
  Yeast: >20 hour
  E.coli: ?

Extinction Coefficient cystines  125

Absorbance 280nm  4.31

Polar residues  9

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22783018

Title  Effects of a single nucleotide polymorphism in the chicken NK-lysin gene on antimicrobial activity and cytotoxicity of cancer cells

Doi 10.1073/pnas.1209161109

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.